コンテンツへスキップ
Merck
  • Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropylphenyl)amino]nicotinic acid skeleton in rat and human liver microsomes.

Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropylphenyl)amino]nicotinic acid skeleton in rat and human liver microsomes.

Drug development and industrial pharmacy (2013-06-21)
Yoshiki Murakami, Yasumasa Shimizu, Akemi Ogasawara, Satoshi Ueshima, Mariko Nakayama, Kohei Kawata, Hiroki Kakuta, Tetsuya Aiba
要旨

The hepatic metabolism of six compounds newly synthesized as retinoid X receptor agonists was characterized in rat and human liver microsomes to examine the relationship between their hepatic metabolism profiles and side chain structures, considering the interspecies difference. The compounds used have a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic or 6-[N-ethyl-N-(4-alkoxy-3-isopropylphenyl)amino]nicotinic acid skeleton, in which the isopropoxy, isobutoxy or cyclopropylmethoxy group is employed for the alkoxy group. These compounds were incubated with the microsomes, and their Michaelis--Menten parameters were determined. The incubation study was also performed with various cytochrome P450 (CYP) inhibitors to examine their susceptibilities to the inhibitors. In addition, a molecular docking simulation was conducted to assess the compound's spatial configuration with the CYP isoform when necessary. The Michaelis--Menten parameters determined are comparable between rats and humans for the compounds having 3-isobutoxy, 4-isobutoxy, 4-isopropoxy and 4-cyclopropylmethoxy groups. However, it was indicated that all compounds except that having the 3-isobutoxy group are metabolized in a different manner between rats and humans. That is, the extent of the contribution of each CYP isozyme is different between those two species. A molecular docking simulation showed that the spatial configuration of the compound to be associated with CYP2D6 markedly changes depending on whether the isobutoxy group is situated at the 3- or 4-position. A slight difference in the side chain structures markedly alters the compound's metabolic profile, which amplifies the interspecies difference regarding the profile, increasing the difficulty in characterizing the profile in humans with the structural-property relationship and interspecies extrapolation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
エチルアルコール(純粋), 200 proof, for molecular biology
Sigma-Aldrich
エタノール, JIS special grade, ≥99.5%
Sigma-Aldrich
エタノール, SAJ first grade, ≥99.5%
Sigma-Aldrich
エチルアルコール(純粋), 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
エタノール, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
エタノール 溶液, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
エタノール, puriss. p.a., absolute, ≥99.8% (GC)
Sigma-Aldrich
ケトコナゾール, 99.0-101.0% (EP, titration)
Sigma-Aldrich
キニジン, anhydrous
Supelco
エタノール標準品10% (v/v), 10 % (v/v) in H2O, analytical standard
USP
エタノール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
キニジン, crystallized, ≥98.0% (dried material, NT)
Sigma-Aldrich
エタノール, ≥99.5%, suitable for HPLC
Sigma-Aldrich
エタノール, JIS special grade, 94.8-95.8%
Sigma-Aldrich
エタノール, ≥99.5%
USP
ケトコナゾール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
エタノール, ≥99.5%, suitable for absorption spectrum analysis
Sigma-Aldrich
Ethanol Fixative 80% v/v, suitable for fixing solution (blood films)
Supelco
ケトコナゾール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
エタノール, JIS first grade, 94.8-95.8%
Supelco
8-メトキシソラレン, analytical standard
Supelco
スルファジメトキシン, VETRANAL®, analytical standard
Supelco
スルファジメトキシン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
エタノール, ≥99.5%, SAJ super special grade
Supelco
スルファジメトキシン, 98.0-102.0%
Sigma-Aldrich
エタノール, ≥99.5%, suitable for fluorescence
Sigma-Aldrich
エタノール, JIS 1000, ≥99.5%, for residue analysis
ケトコナゾール, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
エタノール, JIS 300, ≥99.5%, for residue analysis
Supelco
8-メトキシソラレン, analytical standard